Living Cell Financials
| LVCLF Stock | USD 0 0 166.67% |
Living |
Living Cell Stock Summary
Living Cell competes with Diageo PLC, Black Mammoth, Fomento Economico, MYT Netherlands, and Anheuser Busch. Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. The company was founded in 1987 and is based in Sydney, Australia. Living Cell operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Tower 2, Sydney, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.lctglobal.com |
| Phone | 61 3 8689 9997 |
| Currency | USD - US Dollar |
Living Cell Key Financial Ratios
There are many critical financial ratios that Living Cell's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Living Cell Technologies reports annually and quarterly.Living Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Living Cell's current stock value. Our valuation model uses many indicators to compare Living Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Living Cell competition to find correlations between indicators driving Living Cell's intrinsic value. More Info.Living Cell Technologies is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Living Cell's earnings, one of the primary drivers of an investment's value.Living Cell Technologies Systematic Risk
Living Cell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Living Cell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Living Cell Technologies correlated with the market. If Beta is less than 0 Living Cell generally moves in the opposite direction as compared to the market. If Living Cell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Living Cell Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Living Cell is generally in the same direction as the market. If Beta > 1 Living Cell moves generally in the same direction as, but more than the movement of the benchmark.
Living Cell March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Living Cell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Living Cell Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Living Cell Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Living Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Living Cell's daily price indicators and compare them against related drivers.
| Downside Deviation | 52.18 | |||
| Information Ratio | 0.1282 | |||
| Maximum Drawdown | 369.94 | |||
| Value At Risk | (26.47) | |||
| Potential Upside | 66.67 |
Complementary Tools for Living Pink Sheet analysis
When running Living Cell's price analysis, check to measure Living Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Living Cell is operating at the current time. Most of Living Cell's value examination focuses on studying past and present price action to predict the probability of Living Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Living Cell's price. Additionally, you may evaluate how the addition of Living Cell to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |